Kane Biotech (TSXV:KNE) Momentum Rank : 3 (As of Jun. 05, 2024)

View and export this data going back to 2003. Start your Free Trial

What is Kane Biotech Momentum Rank?

Kane Biotech has the Momentum Rank of 3.

For Momentum Rank, we considered the residual momentum concept that was widely studied by Blitz and his colleagues as well as by Nobel Prize laureates Fama and French. However, we did not find any significant differences in the performances of stocks with different ranks of residual momentum. Therefore, we use traditional momentum instead.

Momentum Rank is determined using the standardized momentum ratio and other momentum indicators. The standardized momentum ratio is the average of the performances from 12 months ago to 1 month ago and 6 months ago to 1 month ago, divided by the beta of the stock over the past 12 months. To calculate the momentum ratio today, we would use the average of the two performance numbers.

For momentum, we found that stock price performance does not have a monotonic correlation with the momentum ratio. The stocks with the highest momentum ratios perform worse than those at about the 70th percentile. Therefore, for the momentum rank, we ranked the stocks at about the 70th percentile of the momentum ratio as the highest at 10.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Competitive Comparison of Kane Biotech's Momentum Rank

For the Biotechnology subindustry, Kane Biotech's Momentum Rank, along with its competitors' market caps and Momentum Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kane Biotech's Momentum Rank Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kane Biotech's Momentum Rank distribution charts can be found below:

* The bar in red indicates where Kane Biotech's Momentum Rank falls into.

Kane Biotech Momentum Rank Related Terms

Thank you for viewing the detailed overview of Kane Biotech's Momentum Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Kane Biotech (TSXV:KNE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kane Biotech Inc (TSXV:KNE) » Definitions » Momentum Rank

Comparable Companies

Traded in Other Exchanges

KNBIF:USA

Address

290-100 Innovation Drive, Winnipeg, MB, CAN, R3T 6G2

Website

https://www.kanebiotech.com

Kane Biotech Inc is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The company has a portfolio of biotechnologies, intellectual property and products developed by its own biofilm research expertise and acquired from research institutions. The Company has a separate operating segment for its Stem Animal Health subsidiary, which operates the animal health business. StrixNB, DispersinB, Aledex, bluestem, bluestem, silkstem, goldstem, coactiv+, DermaKB and DermaKB Biofilm are trademarks of the company. The firm is also engaged in the animal health business through its Stem Animal Health subsidiary.

Executives

Philip Renaud

Director

Kane Biotech (TSXV:KNE) Headlines

No Headlines